Remove Aortic Remove Heart Failure Remove Heart Valves
article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.

Tricuspid 102
article thumbnail

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

article thumbnail

Transcatheter MViR Identified as Reasonable Alternative For Patients With High Surgical Risk

American College of Cardiology

Transcatheter mitral valve-in-ring (MViR) using third-generation balloon-expandable aortic transcatheter heart valves was associated with a significant reduction in mitral regurgitation (MR) and improvement in heart failure symptoms at one year, with the tradeoff of elevated valvular gradients and a high rate of reintervention, according to a recent (..)

article thumbnail

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

European Journal of Heart Failure

Rates of concomitant tricuspid valve (TV) intervention at the time of left-sided heart valve surgery were high at the time of mitral valve surgery (50% when mitral stenosis, 41% when MR). An increase in TR grade was associated with a more severe clinical presentation and a poorer 6-month survival ( p  < 0.0001).

article thumbnail

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

Photo courtesy of Mount Sinai Health System milla1cf Thu, 02/22/2024 - 13:47 February 22, 2024 — Ismail El-Hamamsy , MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B.

article thumbnail

AHA Raises Awareness on HVD

DAIC

22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. This year on Heart Valve Disease Awareness Day (Feb. tim.hodson Tue, 03/04/2025 - 14:11 Feb.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.